January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

BMI falls short as a way to measure obesity. Doctors need to also determine whether body fat harms a person's health.

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Proponents of Ozempic microdosing claim you'll reap the drug's benefits with fewer side effects. But is taking small doses of GLP-1 agonists safe and effective for weight loss?

On Tuesday, New York Governor Kathy Hochul announced a new initiative to expand access to healthcare coverage for popular ...

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

Eli Lilly (LLY) revised its revenue outlook on Tuesday for the fourth quarter of 2024 on weaker-than-expected demand for its ...

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

The company said it overestimated demand of its obesity and diabetes drugs in the fourth quarter, but projected a further ...

Dario's move follows the success of GLP-1 giants Novo Nordisk and Eli Lilly, whose treatments have reshaped the market. However, while the market leaders focus on medications alone, Dario's ...

Turning to 2025 guidance, Lilly noted that new medicines and new uses of existing medicines, expansion of production, and ...